Kiora Pharmaceuticals Management
Management criteria checks 4/4
Kiora Pharmaceuticals' CEO is Brian Strem, appointed in Jul 2021, has a tenure of 2.92 years. total yearly compensation is $802.27K, comprised of 51.9% salary and 48.1% bonuses, including company stock and options. directly owns 0.49% of the company’s shares, worth $60.30K. The average tenure of the management team and the board of directors is 2.7 years and 3.2 years respectively.
Key information
Brian Strem
Chief executive officer
US$802.3k
Total compensation
CEO salary percentage | 51.9% |
CEO tenure | 2.9yrs |
CEO ownership | 0.5% |
Management average tenure | 2.7yrs |
Board average tenure | 3.2yrs |
Recent management updates
Recent updates
Why Kiora Pharmaceuticals' (NASDAQ:KPRX) Earnings Are Better Than They Seem
May 21Kiora pharmaceuticals regains compliance with Nasdaq minimum bid price requirement
Oct 13Kiora Pharma announces 1-for-40 reverse stock split
Sep 26Kiora Pharmaceuticals reports 1H results
Aug 12Kiora gets US patent for KIO-201 use with antibiotics for eye wound healing
Jul 28Kiora Pharmaceuticals prices $5.2M underwritten public offering
Jul 22Kiora begins enrolling in phase 2 trial of wound healing eye drops KIO-201
Jul 05EyeGate Pharmaceuticals announces $8M private placement
Jan 06EyeGate surge in premarket as it acquires Panoptes Pharma for $4M
Dec 21CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Mar 31 2024 | n/a | n/a | US$2m |
Dec 31 2023 | US$802k | US$416k | -US$13m |
Sep 30 2023 | n/a | n/a | -US$13m |
Jun 30 2023 | n/a | n/a | -US$12m |
Mar 31 2023 | n/a | n/a | -US$12m |
Dec 31 2022 | US$714k | US$400k | -US$14m |
Sep 30 2022 | n/a | n/a | -US$17m |
Jun 30 2022 | n/a | n/a | -US$15m |
Mar 31 2022 | n/a | n/a | -US$15m |
Dec 31 2021 | US$659k | US$169k | -US$14m |
Compensation vs Market: Brian's total compensation ($USD802.27K) is about average for companies of similar size in the US market ($USD683.97K).
Compensation vs Earnings: Brian's compensation has been consistent with company performance over the past year.
CEO
Brian Strem (44 yo)
2.9yrs
Tenure
US$802,274
Compensation
Dr. Brian M. Strem, Ph D., is Co-Founder and Director at Okogen, Inc. He served as Principal Financial and Accounting Officer of Kiora Pharmaceuticals, Inc. since June 16, 2022. He serves as President, Dir...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 2.9yrs | US$802.27k | 0.49% $ 60.3k | |
Executive Vice President of Finance | 1.8yrs | US$387.48k | 0.13% $ 16.5k | |
Chief Development Officer | 2.7yrs | US$652.31k | 0.38% $ 46.6k | |
Executive Vice President of CMC & Operations | no data | no data | no data |
2.7yrs
Average Tenure
44yo
Average Age
Experienced Management: KPRX's management team is considered experienced (2.7 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 2.9yrs | US$802.27k | 0.49% $ 60.3k | |
Member of Scientific Advisory Board | 7.3yrs | no data | no data | |
Independent Chairman of the Board | 16yrs | US$98.25k | 0.00040% $ 49.3 | |
Member of Scientific Advisory Board | 6.7yrs | no data | no data | |
Director | 3.2yrs | US$70.12k | 0% $ 0 | |
Independent Director | 3.2yrs | US$92.62k | 0% $ 0 | |
Member of Scientific Advisory Board | 6.3yrs | no data | no data | |
Independent Director | 2.5yrs | US$77.62k | 0% $ 0 | |
Non-Employee Independent Director | 2.3yrs | US$84.50k | 0.18% $ 21.8k | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data |
3.2yrs
Average Tenure
49.5yo
Average Age
Experienced Board: KPRX's board of directors are considered experienced (3.2 years average tenure).